Mitochondrial dysregulation plays a central role in cancers and drives reactive oxygen species (ROS)-dependent tumor progression. We investigated the pro-tumoral roles of mitochondrial dynamics and altered intracellular ROS levels in pancreatic ductal adenocarcinoma (PDAC). We identified 'family with sequence similarity 49 member B' (FAM49B) as a mitochondria-localized protein that regulates mitochondrial fission and cancer progression. Silencing FAM49B in PDAC cells resulted in increased fission and mitochondrial ROS generation, which enhanced PDAC cell proliferation and invasion. Notably, FAM49B expression levels in PDAC cells were downregulated by the tumor microenvironment. Overall, the results of this study show that FAM49B acts as a suppressor of cancer cell proliferation and invasion in PDAC by regulating tumor mitochondrial redox reactions and metabolism.Oncogene advance online publication, 23 October 2017; doi:10.1038/onc.2017.358.
FAM49B, a novel regulator of mitochondrial function and integrity that suppresses tumor metastasis
MS Chattaragada;C Riganti;M Sassoe;M Principe;C Roux;C Curcio;P Cappello;F Novelli
Last
2018-01-01
Abstract
Mitochondrial dysregulation plays a central role in cancers and drives reactive oxygen species (ROS)-dependent tumor progression. We investigated the pro-tumoral roles of mitochondrial dynamics and altered intracellular ROS levels in pancreatic ductal adenocarcinoma (PDAC). We identified 'family with sequence similarity 49 member B' (FAM49B) as a mitochondria-localized protein that regulates mitochondrial fission and cancer progression. Silencing FAM49B in PDAC cells resulted in increased fission and mitochondrial ROS generation, which enhanced PDAC cell proliferation and invasion. Notably, FAM49B expression levels in PDAC cells were downregulated by the tumor microenvironment. Overall, the results of this study show that FAM49B acts as a suppressor of cancer cell proliferation and invasion in PDAC by regulating tumor mitochondrial redox reactions and metabolism.Oncogene advance online publication, 23 October 2017; doi:10.1038/onc.2017.358.File | Dimensione | Formato | |
---|---|---|---|
Chattagarada, Oncogene MS and Supporting, 2018.pdf
Accesso aperto
Descrizione: Chattagarada, MS and Supporting information, 2018
Tipo di file:
PDF EDITORIALE
Dimensione
11.09 MB
Formato
Adobe PDF
|
11.09 MB | Adobe PDF | Visualizza/Apri |
Chattaragada et al_Oncogene_2017.pdf
Accesso riservato
Tipo di file:
PDF EDITORIALE
Dimensione
4.53 MB
Formato
Adobe PDF
|
4.53 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.